Posted On: 11/10/2014 11:25:01 AM
Post# of 98266
SPIR is a huge buying opp. just noticed this:As previously disclosed, in September 2013, Spire Corporation (the “Company”) sold its biomedical business (the “Bio Business Unit”) to N2 Biomedical LLC (“N2 Bio”). The purchase price for the Bio
Business Unit was $10.5 million plus the assumption of liabilities of approximately $0.1 million, with $6.0 million paid in cash at closing, a $2.4 million subordinated convertible promissory note (the “N2 Note”),
and 310,549 Series A Preferred Units of N2 (the “N2 Units”) valued at approximately $2.1 million.
market cap only $3.5m...
check recent news( after the one posted above) first time since they delisted from nasdaq.
this is going to dollars imo
Business Unit was $10.5 million plus the assumption of liabilities of approximately $0.1 million, with $6.0 million paid in cash at closing, a $2.4 million subordinated convertible promissory note (the “N2 Note”),
and 310,549 Series A Preferred Units of N2 (the “N2 Units”) valued at approximately $2.1 million.
market cap only $3.5m...
check recent news( after the one posted above) first time since they delisted from nasdaq.
this is going to dollars imo
(0)
(0)Scroll down for more posts ▼
